Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “targeted”

263 pharma patents match "targeted" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 263
Index total 30,257
Page 6 / 11

Quick answer

This filtered view shows 263 pharmaceutical patents matching "targeted" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

263 results for “targeted” · 30,257 patents in full index Clear search

  1. US 10500277

    Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma

    EnGeneIC Molecular Delivery Pty Ltd · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  2. US 10485879

    Plasma cell cytokine vehicle containing fusion proteins for targeted introduction of siRNA into cells and tissues

    Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, National Institutes Of Health · Granted Nov 26, 2019 · Expires Nov 21, 2039

    granted

  3. US 10414656

    Discrete carbon nanotubes with targeted oxidation levels and formulations thereof

    MOLECULAR REBAR DESIGN, LLC · Granted Sep 17, 2019 · Expires Sep 12, 2039

    granted

  4. US 10401361

    Intracellular organelle peptide targeted enzyme substrates

    Marker Gene Technologies, Inc · Granted Sep 3, 2019 · Expires Aug 29, 2039

    granted

  5. US 10376598

    Targeted therapeutics

    Madrigal Pharmaceuticals, Inc. · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted

  6. US 10370680

    Method of treating factor IX deficiency using nuclease-mediated targeted integration

    Sangamo Therapeutics, Inc. · Granted Aug 6, 2019 · Expires Aug 1, 2039

    granted

  7. US 10328109

    Targeted adenoviruses and methods of making, isolating, and using

    Regents of the University of Minnesota · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted

  8. US 10316316

    Compositions for targeted delivery of siRNA

    Arrowhead Pharmaceuticals, Inc. · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

  9. US 10300113

    Targeted therapeutic proteins

    BIOMARIN PHARMACEUTICAL INC. · Granted May 28, 2019 · Expires May 23, 2039

    granted

  10. US 10301369

    Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteins

    BIOMARIN PHARMACEUTICAL INC. · Granted May 28, 2019 · Expires May 23, 2039

    granted

  11. US 10245322

    Nanostructured carriers for guided and targeted on-demand substance delivery

    The Regents of the University of California · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted

  12. US 10232049

    Targeted therapeutics

    Madrigal Pharmaceuticals, Inc. · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  13. US 10184004

    CD47 targeted therapies for the treatment of infectious disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  14. US 10182984

    Targeted interferons demonstrate potent apoptotic and anti-tumor activities

    The Regents of the University of California · Granted Jan 22, 2019 · Expires Jan 17, 2039

    granted

  15. US 10155011

    Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases

    Sangamo Therapeutics, Inc. · Granted Dec 18, 2018 · Expires Dec 13, 2038

    granted

  16. US 10125171

    Cell-reactive, long-acting, or targeted compstatin analogs and uses thereof

    Apellis Pharmaceuticals, Inc. · Granted Nov 13, 2018 · Expires Nov 8, 2038

    granted

  17. US 10117944

    Targeted therapeutics

    Madrigal Pharmaceuticals, Inc. · Granted Nov 6, 2018 · Expires Nov 1, 2038

    granted

  18. US 10113207

    Methods and compositions for targeted single-stranded cleavage and targeted integration

    Sangamo Therapeutics, Inc. · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  19. US 10111926

    Selectively targeted antimicrobial peptides and the use thereof

    The Regents of the University of California · Granted Oct 30, 2018 · Expires Oct 25, 2038

    granted

  20. US 10046057

    Methods for arranging and packing nucleic acids for unusual resistance to nucleases and targeted delivery for gene therapy

    The Regents of the University of California · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  21. US 10035822

    Cell-reactive, long-acting, or targeted compstatin analogs and related compositions and methods

    Apellis Pharmaceuticals, Inc. · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  22. US 10034919

    Targeted human-interferon fusion proteins

    Universite Montepellier 2 · Granted Jul 31, 2018 · Expires Jul 26, 2038

    granted

  23. US 10029017

    Pretargeted activatable cell penetrating peptide with intracellularly releasable prodrug

    The Regents of the University of California · Granted Jul 24, 2018 · Expires Jul 19, 2038

    granted

  24. US 9993553

    Methods and compositions for targeted release of molecules from nanoscale carriers

    The Regents of the University of California · Granted Jun 12, 2018 · Expires Jun 7, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.